280 related articles for article (PubMed ID: 25699419)
1. An immunosuppressive antibody-drug conjugate.
Wang RE; Liu T; Wang Y; Cao Y; Du J; Luo X; Deshmukh V; Kim CH; Lawson BR; Tremblay MS; Young TS; Kazane SA; Wang F; Schultz PG
J Am Chem Soc; 2015 Mar; 137(9):3229-32. PubMed ID: 25699419
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia.
Harr MW; Caimi PF; McColl KS; Zhong F; Patel SN; Barr PM; Distelhorst CW
Cell Death Differ; 2010 Sep; 17(9):1381-91. PubMed ID: 20300113
[TBL] [Abstract][Full Text] [Related]
3. The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells.
Mestermann K; Giavridis T; Weber J; Rydzek J; Frenz S; Nerreter T; Mades A; Sadelain M; Einsele H; Hudecek M
Sci Transl Med; 2019 Jul; 11(499):. PubMed ID: 31270272
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.
Laukkanen S; Veloso A; Yan C; Oksa L; Alpert EJ; Do D; Hyvärinen N; McCarthy K; Adhikari A; Yang Q; Iyer S; Garcia SP; Pello A; Ruokoranta T; Moisio S; Adhikari S; Yoder JA; Gallagher K; Whelton L; Allen JR; Jin AH; Loontiens S; Heinäniemi M; Kelliher M; Heckman CA; Lohi O; Langenau DM
Blood; 2022 Oct; 140(17):1891-1906. PubMed ID: 35544598
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Kv1.3 channels by protein kinase A I in T lymphocytes is mediated by the disc large 1-tyrosine kinase Lck complex.
Kuras Z; Kucher V; Gordon SM; Neumeier L; Chimote AA; Filipovich AH; Conforti L
Am J Physiol Cell Physiol; 2012 May; 302(10):C1504-12. PubMed ID: 22378744
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.
Schade AE; Schieven GL; Townsend R; Jankowska AM; Susulic V; Zhang R; Szpurka H; Maciejewski JP
Blood; 2008 Feb; 111(3):1366-77. PubMed ID: 17962511
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of T cells by γ2-herpesviral GPCR through the interaction with cellular CXCR4.
Kwon EK; Min CK; Kim Y; Lee JW; Aigerim A; Schmidt S; Nam HJ; Han SK; Kim K; Cha JS; Kim H; Kim S; Cho HS; Choi MS; Cho NH
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):1-11. PubMed ID: 27751885
[TBL] [Abstract][Full Text] [Related]
8. Update on lymphocyte specific kinase inhibitors: a patent survey.
Martin MW; Machacek MR
Expert Opin Ther Pat; 2010 Nov; 20(11):1573-93. PubMed ID: 20831362
[TBL] [Abstract][Full Text] [Related]
9. Interplay between the heterotrimeric G-protein subunits Galphaq and Galphai2 sets the threshold for chemotaxis and TCR activation.
Ngai J; Inngjerdingen M; Berge T; Taskén K
BMC Immunol; 2009 May; 10():27. PubMed ID: 19426503
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia.
Hu J; Jarusiewicz J; Du G; Nishiguchi G; Yoshimura S; Panetta JC; Li Z; Min J; Yang L; Chepyala D; Actis M; Reyes N; Smart B; Pui CH; Teachey DT; Rankovic Z; Yang JJ
Sci Transl Med; 2022 Aug; 14(659):eabo5228. PubMed ID: 36001679
[TBL] [Abstract][Full Text] [Related]
11. Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases.
Yorgin PD; Hartson SD; Fellah AM; Scroggins BT; Huang W; Katsanis E; Couchman JM; Matts RL; Whitesell L
J Immunol; 2000 Mar; 164(6):2915-23. PubMed ID: 10706677
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.
Fernandis AZ; Cherla RP; Ganju RK
J Biol Chem; 2003 Mar; 278(11):9536-43. PubMed ID: 12519755
[TBL] [Abstract][Full Text] [Related]
13. A CXCR4-targeted site-specific antibody-drug conjugate.
Kularatne SA; Deshmukh V; Ma J; Tardif V; Lim RK; Pugh HM; Sun Y; Manibusan A; Sellers AJ; Barnett RS; Srinagesh S; Forsyth JS; Hassenpflug W; Tian F; Javahishvili T; Felding-Habermann B; Lawson BR; Kazane SA; Schultz PG
Angew Chem Int Ed Engl; 2014 Oct; 53(44):11863-7. PubMed ID: 25213874
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase Lck.
Ghosh MC; Baatar D; Collins G; Carter A; Indig F; Biragyn A; Taub DD
Blood; 2009 Jan; 113(3):575-84. PubMed ID: 18840710
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
[TBL] [Abstract][Full Text] [Related]
16. T cell-specific adapter protein inhibits T cell activation by modulating Lck activity.
Sundvold V; Torgersen KM; Post NH; Marti F; King PD; Røttingen JA; Spurkland A; Lea T
J Immunol; 2000 Sep; 165(6):2927-31. PubMed ID: 10975797
[TBL] [Abstract][Full Text] [Related]
17. Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALL.
Leonard JT; Kosaka Y; Malla P; LaTocha D; Lamble A; Hayes-Lattin B; Byrd K; Druker BJ; Tyner JW; Chang BH; Lind E
Blood; 2021 Feb; 137(7):939-944. PubMed ID: 32898857
[TBL] [Abstract][Full Text] [Related]
18. Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates.
Costa MJ; Kudaravalli J; Ma JT; Ho WH; Delaria K; Holz C; Stauffer A; Chunyk AG; Zong Q; Blasi E; Buetow B; Tran TT; Lindquist K; Dorywalska M; Rajpal A; Shelton DL; Strop P; Liu SH
Sci Rep; 2019 Feb; 9(1):2443. PubMed ID: 30792442
[TBL] [Abstract][Full Text] [Related]
19. TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues.
Nyakeriga AM; Garg H; Joshi A
Cytometry A; 2012 Sep; 81(9):797-805. PubMed ID: 22674786
[TBL] [Abstract][Full Text] [Related]
20. Subcellular distribution of Lck during CD4 T-cell maturation in the thymic medulla regulates the T-cell activation threshold.
Stephen TL; Wilson BS; Laufer TM
Proc Natl Acad Sci U S A; 2012 May; 109(19):7415-20. PubMed ID: 22529380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
